As of 2025-09-17, the Relative Valuation of Stoke Therapeutics Inc (STOK) is 28.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.16 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is 22.4%.
The range of the Relative Valuation is 23.18 - 32.75 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 30.4x | 27.3x |
| Forward P/E multiples | 29.6x - 34.2x | 31.9x |
| Fair Price | 23.18 - 32.75 | 28.35 |
| Upside | 0.1% - 41.4% | 22.4% |
| Date | P/E |
| 2025-09-08 | 23.22 |
| 2025-09-05 | 21.59 |
| 2025-09-04 | 20.50 |
| 2025-09-03 | 20.64 |
| 2025-09-02 | 20.45 |
| 2025-08-29 | 20.63 |
| 2025-08-28 | 20.64 |
| 2025-08-27 | 20.15 |
| 2025-08-26 | 20.22 |
| 2025-08-25 | 19.70 |
| 2025-08-22 | 20.42 |
| 2025-08-21 | 20.55 |
| 2025-08-20 | 20.17 |
| 2025-08-19 | 19.31 |
| 2025-08-18 | 19.33 |
| 2025-08-15 | 19.01 |
| 2025-08-14 | 17.93 |
| 2025-08-13 | 17.66 |
| 2025-08-12 | 14.13 |
| 2025-08-11 | 13.74 |
| 2025-08-08 | 13.68 |
| 2025-08-07 | 13.83 |
| 2025-08-06 | 13.75 |
| 2025-08-05 | 13.53 |
| 2025-08-04 | 13.72 |
| 2025-08-01 | 13.48 |
| 2025-07-31 | 13.42 |
| 2025-07-30 | 13.44 |
| 2025-07-29 | 13.05 |
| 2025-07-28 | 13.38 |
| 2025-07-25 | 13.68 |
| 2025-07-24 | 14.11 |
| 2025-07-23 | 14.90 |
| 2025-07-22 | 14.17 |
| 2025-07-21 | 12.85 |
| 2025-07-18 | 13.80 |
| 2025-07-17 | 12.89 |
| 2025-07-16 | 12.43 |
| 2025-07-15 | 12.27 |
| 2025-07-14 | 12.59 |
| 2025-07-11 | 12.38 |
| 2025-07-10 | 12.57 |
| 2025-07-09 | 12.55 |
| 2025-07-08 | 12.54 |
| 2025-07-07 | 12.21 |
| 2025-07-03 | 11.99 |
| 2025-07-02 | 12.06 |
| 2025-07-01 | 12.16 |
| 2025-06-30 | 11.85 |
| 2025-06-27 | 12.14 |